home / stock / nvs / nvs articles

NVS Articles, Novartis AG - From 03/06/24

Stock Information
Company Name: Novartis AG
Stock Symbol: NVS
Market: NYSE
Website: novartis.com
Menu
NVS NVS Quote NVS Short NVS News NVS Articles NVS Message Board
Get NVS Alerts

News, Short Squeeze, Breakout and More Instantly...
Biogen's Spinraza For Muscle Movement Disorder Shows Improved Motor Function In Infants, Toddlers | Benzinga

Biogen Inc (NASDAQ:BIIB) released interim 6-month biomarker data from the initial 29 participants in the open-label RESPOND study. The Ph...
Biden's State Of The Union: Grading His Results On Abortion Access, Drug Prices And Opium Epidemic | Benzinga

As President Joe Biden prepares for his State of the Union address on Thursday, he's expected to touch on several key issues including Bidenom...

Novartis Reveals Promising Gene Therapy Data for Treating Spinal Muscular Atrophy in Older Children | Benzinga

Monday, Novartis AG (NYSE:NVS) presented new data for Zolgensma (onasemnogene abeparvovec), a one-time gene therapy for the tre...

This Drug By Roche And Novartis Reduces Allergic Reactions Across Multiple Foods For People With Food Allergies | Benzinga

Monday, Roche Holdings AG (OTC:RHHBY) announced data from Stage 1 of the National Institutes of Health (NIH)-sponsored pivotal ...
Biogen Could Engage In $1B-$2B Deals To Fill Revenue Shortfall Gaps, Analyst Says | Benzinga

Tuesday, Biogen Inc (NASDAQ:BIIB) posted fourth-quarter 2023 sales of $2.39 billion, missing the consensus of $2.46 billion, down 6% Y/Y ...

JP Morgan's Bullish View On This Chinese Biotech, Says Pullback Creates Entry Point | Benzinga

JP Morgan assumed coverage on BeiGene Ltd (NASDAQ:BGNE), highlighting the potential upside and emphasizing that the recent pullback ...

Novartis Agrees To Acquire German Blood Cancer-Drug Developer MorphoSys For €2.7B | Benzinga

Monday, Novartis AG (NYSE:NVS) made a voluntary public takeover offer to acquire MorphoSys AG (NASDAQ:MOR) for ?...
MorphoSys Stock Soars After Report Says Novartis To Acquire Cancer-Drug Developer | Benzinga

MorphoSys AG (NASDAQ:MOR) shares are trading higher Monday following a report suggesting Novartis AG (NYSE:NVS) is in talks to acquire the company....

Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations | Benzinga

Under the Inflation Reduction Act, Medicare is poised to send initial offers to manufacturers of the first ten drugs chosen for negotiation, challe...

Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter ...
Previous 10 Next 10